계정 가입
이미 존재한 계정
가입을 클릭하여 코인타임의 <a class="underline" href="#term-of-service">서비스 약관</a> 과 a class="underline" href="#privacy-policy">개인정보 보호 정책</a> . 에 동의함.
email 로 로그인
email 로 가입
사용자 이메일
수신함을 확인하세요
중의 링크를 통해 로그인 하세요
중의 링크를 통해 가입 하세요
Shanghai Cell Therapy Group
company
About
Shanghai Cell Therapy Group is a provider of cellular diagnosis center combining cellular research and treatment services.
- 251 - 500
Details
- Last Funding Type
- Series D
- Last Funding Money Raised
- ¥500M
- Industries
- Biotechnology,Therapeutics
- Founded date
- Nov 29, 2013
- Number Of Employee
- 251 - 500
- Operating Status
- Active
Shanghai Cell Therapy Group is a provider of cellular diagnosis center combining cellular research and treatment services.The company is involved in cellular cold storage, cellular pharmaceuticals, antibody research, enabling patients to do genetic testing and providing research data to cancer facilities.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
3
¥1.70B
Shanghai Cell Therapy Group has raised a total of
¥1.70B
in funding over 2 rounds. Their latest funding was raised on
Mar 24, 2021 from a Series D round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Mar 24, 2021 | Series D | ¥500M | 1 | — | — | Detail |
| Dec 18, 2018 | Series C | ¥0.92B | 1 |
China Industrial Asset Management
|
— | Detail |
| Nov 26, 2018 | Series C | ¥275M | 1 |
China Industrial Asset Management
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
2
2
Shanghai Cell Therapy Group is funded by 2 investors.
China Industrial Asset Management
and Jiuzhou Venture
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
China Industrial Asset Management
|
Yes | Series C |
Jiuzhou Venture
|
— | Series D |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
